Testing Patterns for CKD-MBD Abnormalities in a Sample US Population.

ABSTRACT:

Introduction

Patterns of testing, treatment, and retesting following treatment for disorders of chronic kidney disease mineral bone disorder (CKD-MBD) have not been explored using a large electronic database.

Methods

To determine concordance with CKD-MBD management guidelines, we used 2010 to 2019 data from an electronic health record (>50 million patients) to create cohorts of incident CKD stage 3, 4, and 5 patients using diagnosis codes and estimated glomerular filtration rates. The CKD-MBD test ordering and relevant drug prescribing were assessed during follow-up. We estimated cumulative incidence of posttreatment retesting (death as competing risk). We used multivariable Cox regression to examine baseline characteristics and pretreatment test results as predictors of ret

SUBMITTER: Wetmore JB 

PROVIDER: S-EPMC8071625 | biostudies-literature | 2021 Apr

REPOSITORIES: biostudies-literature